Alpha 2.0
Login Register
» Articles » PMID: 36004936

Premature Aging of the Immune System Affects The response to SARS-CoV-2 MRNA Vaccine In β-thalassemia: Role of an Additional Dose

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2022 Aug 25
PMID 36004936
Authors
Rita Carsetti
Chiara Agrati
Valeria Maria Pinto
Barbara Gianesin
Rita Gamberini
Monica Fortini
Susanna Barella
Rita Denotti
Silverio Perrotta
Maddalena Casale
Aurelio Maggio
Lorella Pitrolo
Eleonora Tartaglia
Eva Piano Mortari
Francesca Colavita
Vincenzo Puro
Massimo Francalancia
Valeria Marini
Marco Caminati
Filippo Mazzi
Lucia De Franceschi
Gian Luca Forni
Franco Locatelli
Affiliations
Soon will be listed here.
Citing Articles

Absence of blood donors' anti-SARS-CoV-2 antibodies in pre-storage leukoreduced red blood cell units indicates no role of passive immunity for blood recipients.

Casale M, Di Girolamo M, Di Maio N, Tomeo R, Iengo M, Scianguetta S Ann Hematol. 2023; 103(2):623-629.

PMID: 37758964 PMC: 10799091. DOI: 10.1007/s00277-023-05473-2.

Clinical outcome and humoral immune responses of β-thalassemia major patients with severe iron overload to SARS-CoV-2 infection and vaccination: a prospective cohort study.

Ghoti H, Zreid H, Ghoti I, Bourgonje A, Diepstra A, Goor H EClinicalMedicine. 2023; 62:102096.

PMID: 37560260 PMC: 10406963. DOI: 10.1016/j.eclinm.2023.102096.

Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study.

Gamberini M, Zuccato C, Zurlo M, Cosenza L, Finotti A, Gambari R Hematol Rep. 2023; 15(3):432-439.

PMID: 37489374 PMC: 10366771. DOI: 10.3390/hematolrep15030044.

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia.

Malagu M, Longo F, Marchini F, Sirugo P, Capanni A, Clo S Biology (Basel). 2023; 12(4).

PMID: 37106692 PMC: 10136165. DOI: 10.3390/biology12040491.

Emerging viral infections in immunocompromised patients: A great challenge to better define the role of immune response.

Agrati C, Bartolini B, Bordoni V, Locatelli F, Capobianchi M, Di Caro A Front Immunol. 2023; 14:1147871.

PMID: 36969202 PMC: 10035572. DOI: 10.3389/fimmu.2023.1147871.

References
1.
Oosting S, van der Veldt A, Fehrmann R, GeurtsvanKessel C, van Binnendijk R, Dingemans A . Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours. Lancet Oncol. 2022; 23(7):833-835. PMC: 9236566. DOI: 10.1016/S1470-2045(22)00203-0. View
2.
Collier D, Ferreira I, Kotagiri P, Datir R, Lim E, Touizer E . Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature. 2021; 596(7872):417-422. PMC: 8373615. DOI: 10.1038/s41586-021-03739-1. View
3.
Bates T, McBride S, Leier H, Guzman G, Lyski Z, Schoen D . Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants. Sci Immunol. 2022; 7(68):eabn8014. PMC: 8939472. DOI: 10.1126/sciimmunol.abn8014. View
4.
Radbruch A, Muehlinghaus G, Luger E, Inamine A, Smith K, Dorner T . Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol. 2006; 6(10):741-50. DOI: 10.1038/nri1886. View
5.
Balouchi S, Gharagozloo M, Esmaeil N, Mirmoghtadaei M, Moayedi B . Serum levels of TGFβ, IL-10, IL-17, and IL-23 cytokines in β-thalassemia major patients: the impact of silymarin therapy. Immunopharmacol Immunotoxicol. 2014; 36(4):271-4. DOI: 10.3109/08923973.2014.926916. View